Sonova Holding AGXSWX:SOON +0.79%90 ROC (Joel Greenblatt) % is 114.41% as of Mar. 2026, which is 7% above its 10-year median of 106.78. GuruFocus rates XSWX:SOON with a GF Score™ of 90/100 and a GF Value™ of CHF249.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 841 Medical Devices & Instruments companies, Sonova Holding AG ranks better than 96.91% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Sonova Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 114.41%.
The historical rank and industry rank for Sonova Holding AG's ROC (Joel Greenblatt) % or its related term are showing as below:
XSWX:SOON'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 89.73 Med: 106.78 Max: 128.8
Current: 96.7
During the past 13 years, Sonova Holding AG's highest ROC (Joel Greenblatt) % was 128.80%. The lowest was 89.73%. And the median was 106.78%.
XSWX:SOON's ROC (Joel Greenblatt) % is ranked better than 96.91% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 3.94
vs XSWX:SOON: 96.70
Sonova Holding AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -3.40% per year.
Sonova Holding AG (XSWX:SOON) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Sonova Holding AG ROC (Joel Greenblatt) % Related Terms
Sonova Holding AG ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Sonova Holding AG's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SOON vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Sonova Holding AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonova Holding AG ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sonova Holding AG's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Sonova Holding AG's ROC (Joel Greenblatt) % falls into.
Sonova Holding AG ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 114.41% mean?
Sonova Holding AG (XSWX:SOON) has a ROC (Joel Greenblatt) % of 114.41% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sonova Holding AG and its competitors. This is near median its historical median of 106.78. Over the past decade, Sonova Holding AG's ROC (Joel Greenblatt) % has ranged from 89.73 to 128.80. According to the industry distribution chart, Sonova Holding AG ranks #26 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 3.1%.
Is Sonova Holding AG's ROC (Joel Greenblatt) % too high?
Sonova Holding AG's current ROC (Joel Greenblatt) % of 114.41% is near median its 10-year median of 106.78. Over the past 10 years, this metric has ranged from a low of 89.73 to a high of 128.80. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 3.94. Sonova Holding AG's value of 114.41% is 2803.8% above this industry median. Based on the distribution chart, Sonova Holding AG ranks #26 out of 841 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sonova Holding AG has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonova Holding AG's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sonova Holding AG ranks #26 out of 841 companies for ROC (Joel Greenblatt) %. This places Sonova Holding AG in the top 3% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 3.94. Sonova Holding AG's value of 114.41% is 2803.8% above this benchmark. Historically, Sonova Holding AG's own ROC (Joel Greenblatt) % has ranged from 89.73 to 128.80 over the past decade. While the company's 10-year median is 106.78 vs. the industry median of 3.94, Sonova Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 3.94, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sonova Holding AG's current ROC (Joel Greenblatt) % of 114.41% is 2803.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sonova Holding AG and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 3.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonova Holding AG's current ROC (Joel Greenblatt) % is 114.41%, which is near median its own 10-year median of 106.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonova Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Sonova Holding AG (XSWX:SOON) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF249.97, compared to a current price of CHF203.60 — trading 18.6% below its estimated fair value. The current ROC (Joel Greenblatt) % is 114.41%, which is near median its 10-year median of 106.78 and 2803.8% above the Medical Devices & Instruments industry median of 3.94. Sonova Holding AG's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Sonova Holding AG (XSWX:SOON), the current ROC (Joel Greenblatt) % is 114.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sonova Holding AG (XSWX:SOON) Overvalued in 2026?
Based on GuruFocus' analysis, Sonova Holding AG stock appears to be undervalued.
The current stock price of CHF203.60 is trading 18.6% below its estimated GF Value™ of CHF249.97.
GuruFocus considers Sonova Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:SOON:
ROC (Joel Greenblatt) %: 114.41% (near median its 10-year median of 106.78)
GF Value™: CHF249.97 vs. price of CHF203.60 (18.6% below fair value)
Industry Position: 2803.8% above the Medical Devices & Instruments median (#26 of 841)
No single metric tells the full story. See the XSWX:SOON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies.
90GF Score
Get the complete analysis for XSWX:SOON
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SOON has been successfully added to your 
